José Ignacio Jiménez Santos
Chief Investment Officer bei GRUPO FINANCIERO INBURSA, S.A.B. DE C.V.
Profil
José Ignacio Jiménez Santos is currently the Chief Executive Officer at Afore Inbursa SA de CV, and also holds positions as Director at Glycosyn LLC, Independent Director at ProKidney Corp., and Chief Investment Officer at Grupo Financiero Inbursa SAB de CV.
He previously worked as Director at Procesar SA de CV in 2019-2020.
He obtained an undergraduate degree from Instituto Tecnológico Autónomo de México.
Aktive Positionen von José Ignacio Jiménez Santos
| Unternehmen | Position | Beginn |
|---|---|---|
| PROKIDNEY CORP. | Director/Board Member | - |
| GRUPO FINANCIERO INBURSA, S.A.B. DE C.V. | Chief Investment Officer | 01.08.2013 |
Afore Inbursa SA de CV
 Afore Inbursa SA de CV Insurance Brokers/ServicesFinance Part of Grupo Financiero Inbursa SAB de CV, Afore Inbursa SA de CV provides insurance agent and broker services. The private company is based in Mexico City, Mexico. José Ignacio Jiménez Santos has been the CEO of the Mexican company since 2015. | Chief Executive Officer | 01.08.2015 |
Glycosyn LLC
 Glycosyn LLC Pharmaceuticals: MajorHealth Technology Glycosyn LLC is a biotechnology-based company that develops efficient and cost-effective technologies for synthesizing and producing human milk oligosaccharides (HMOs). The private company is based in Medford, MA. HMOs are major health-giving components of human milk, and Glycosyn owns exclusive rights for methods of manufacturing HMOs as well as for their use in treating inflammatory bowel disease and irritable bowel syndrome, and as prebiotics. Glycosyn Health Initiatives (GHI) is a non-profit dedicated to bringing the benefits of HMOs to those who need them most in the developing world. The CEOs of the company are Howard Newburg, John R. Garrett. | Director/Board Member | - |
Ehemalige bekannte Positionen von José Ignacio Jiménez Santos
| Unternehmen | Position | Ende |
|---|---|---|
| Procesar SA de CV | Director/Board Member | 01.05.2020 |
Ausbildung von José Ignacio Jiménez Santos
| Instituto Tecnológico Autónomo de México | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GRUPO FINANCIERO INBURSA, S.A.B. DE C.V. | Finance |
| PROKIDNEY CORP. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Procesar SA de CV | |
Afore Inbursa SA de CV
Afore Inbursa SA de CV Insurance Brokers/ServicesFinance Part of Grupo Financiero Inbursa SAB de CV, Afore Inbursa SA de CV provides insurance agent and broker services. The private company is based in Mexico City, Mexico. José Ignacio Jiménez Santos has been the CEO of the Mexican company since 2015. | Finance |
Glycosyn LLC
Glycosyn LLC Pharmaceuticals: MajorHealth Technology Glycosyn LLC is a biotechnology-based company that develops efficient and cost-effective technologies for synthesizing and producing human milk oligosaccharides (HMOs). The private company is based in Medford, MA. HMOs are major health-giving components of human milk, and Glycosyn owns exclusive rights for methods of manufacturing HMOs as well as for their use in treating inflammatory bowel disease and irritable bowel syndrome, and as prebiotics. Glycosyn Health Initiatives (GHI) is a non-profit dedicated to bringing the benefits of HMOs to those who need them most in the developing world. The CEOs of the company are Howard Newburg, John R. Garrett. | Health Technology |
